Professor Mark Gurnell, MBBS, MA (Med Ed), PhD, FRCP
University of Cambridge
Mark Gurnell obtained his initial medical training at St Bartholomews Hospital, London. In 1996, he moved to Cambridge, as a Clinical Fellow, where he undertook a PhD study investigating the roles of the human thyroid hormone β receptors and the peroxisome proliferator-activated receptor γ. For his work, he received the Medical Research Society's Gold Medal and the Society for Endocrinology's Young Clinical Endocrinologist Prize.
He was appointed to the University Lectureship in 2004, and shortly afterwards he became the Specialty Director for Medicine in the School of Clinical Medicine. In 2009, he became the Clinical Director of Studies at Sidney Sussex College, Cambridge. In 2010, following completion of MA in Medical Education, he was appointed Fellow of the Higher Education Academy.
In 2011, he obtained the University of Cambridge Pilkington Prize for excellence in teaching, and was appointed Associate Clinical Dean (Lead for Assessment) in the Clinical School. He is the clinical lead for pituitary disorders in Cambridge and the Eastern region. He also co-directs a national/international referral service for patients with complex disorders of thyroid function.
His current research interests include (i) the role of nuclear hormone receptors in human disease (ii) genetic and acquired disorders of the hypothalamic-pituitary-thyroid axis (iii) novel approaches to sparing hypothalamic-pituitary function in patients with sellar/parasellar tumours and (iv) functional imaging in endocrine neoplasia.
Dr. Manju Chandran, MBBS, MD, ABIM (Int Med), ABIM (Endocrinology), FACP, FACE, FAMS
Singapore General Hospital
Dr Manju Chandran is a Senior Consultant Endocrinologist and the Director of the Osteoporosis and Bone Metabolism Unit at Singapore General Hospital. She is also the Current Chairperson of the division of Endocrinologists of the College of Physicians, Academy of Medicine, Singapore.
Her research and clinical interests include Secondary Fracture Prevention, metabolic Bone Diseases related to Diabetes, Renal Transplant and Rare Metabolic Bone Diseases and the use of new bio-imaging modalities in Osteoporosis.
She has won numerous international awards including the IOF-ESCEO International Young Investigator Award in 2013 and the prestigious International Osteoporosis Foundation Committee of National Societies Medal in 2015. Her Secondary Fracture Prevention Program at Singapore General Hospital- OPTIMAL was awarded the coveted Gold Star in the Global Capture the Fracture Campaign of the IOF in 2015.
She is an elected member of the Council of Scientific Advisors (CSA) of the International Osteoporosis Foundation, and is a Past President of the Endocrine and Metabolic Society of Singapore (EMSS). She was the Scientific Chairperson of the 6th IOF Asia Pacific Regionals as well as Course Co-Director for the IOF-ISCD Osteoporosis Essentials Course in Singapore in November 2016.
She has published widely in international peer-reviewed journals and is an invited author of editorials and commentaries. Dr. Manju Chandran has been an invited speaker at numerous regional and international conferences in the fields of Endocrinology, Osteoporosis and Bone Metabolism.
Professor Duncan Topliss, MB BS Hons, MD, FRACP, FACE.
Professor Duncan Topliss is the Director of the Department of Endocrinology and Diabetes at the Alfred Hospital Melbourne. He is also the Professor of Medicine in the Department of Medicine, Monash University. Professor Topliss is also a past-President and a Life Member of the Endocrine Society of Australia. He has served on the editorial board of high profile endocrine journals including Journal of Thyroid Research and Clinical Endocrinology and is also a frequent reviewer for journals such as Clinical Endocrinology and Thyroid.
Professor Topliss heads the Diabetes Clinic at the Alfred Hospital, has a long-term interest in diabetes prevention and management. He has been an investigator on several major international diabetes trials.
Professor Topliss has over 25 years of clinical experience in a wide variety of endocrine diseases including osteoporosis, pituitary diseases, adrenal disease, endocrine hypertension, thyroid disease and thyroid cancer. His other area of interest is on drug regulation and safety. He is a member of the Australian Advisory Committee on the Safety of Medicine and the Australian Advisory Committee on Pharmaceutical Medicines of the Therapeutic Goods Administration.
Professor Mark McCarthy, MA, MB, BChir, MD, FRCP, FRSB, FMedSc
University of Oxford
Professor Mark McCarthy is the Professor of Diabetes in the Oxford Centre for Diabetes, Endocrinology & Metabolism at the Oxford University Hospitals NHS Foundation Trust.
Prof. McCarthy has special interest in large scale genetic and genomic data on type 2 diabetes and related phenotypes (including obesity)
The multidisciplinary diabetes research team headed by Prof Mark McCarthy focuses on the identification and characterization of genetic variants linked to type 2 diabetes and translating these information on biological insights and clinical advances. His Diabetic research team is based at both the Oxford Centre for Diabetes, Endocrinology and Metabolism and the Wellcome Trust Centre for Human Genetics.
His most important original findings were on: (i) Mapping of loci contributing to type 2 diabetes (T2D) susceptibility through linkage analysis (ii) Establishing that variants within CAPN10 and KCNJ11 contribute to T2D susceptibility (iii) Establishing the role of variation within the INS and IRS1 genes and susceptibility to diverse metabolic diseases/traits (iv) Understanding the pathophysiology and genetic basis of T2D-related traits including gestational diabetes and polycystic ovary syndrome
Professor Ashley Grossman BA, BSc, MD, FRCP, FMedSci
Professor of Neuroendocrinology.
University of Oxford
Professor Ashley Grossman graduated with a BA in Psychology and Social Anthropology from the University of London. He then entered University College Hospital Medical School in London to complete BSc in Neuroscience. In 1975, he obtained the University Gold Medal. Following junior posts in cardiology and neurology, he then joined the Department of Endocrinology at St Bartholomew's Hospital where he spent most of his career and became the Professor of Neuroendocrinology and Consultant Physician. Following this, he also become Professor of Endocrinology at the University of Oxford in the Oxford Centre for Diabetes, Endocrinology and Metabolism.
In the year 2000, Professor Grossman was appointed a Fellow of the Academy of Medical Sciences. He has published over 700 research papers and reviews, and holds particular interests in pituitary and hypothalamic tumours, endocrine oncology, and the molecular pathogenesis of neuroendocrine tumours. He is a past president of the European Neuroendocrine Association (ENEA) and was the Chairman of the UKI Neuroendocrine Tumour Association(UKINETS). He is a past editor of the journal Clinical Endocrinology and was in the editorial boards of many journals. He has served in the editorial board of the several major textbooks including De Groot and Jameson's Endocrinology. Professor Grossman was also the Vice-Chairman of the major on-line endocrine textbook Endotext.org.
Professor Chantal Mathieu, M.D., Ph.D.
Vice – President - EASD
Katholieke Universiteit Leuven
Chantal Mathieu is Professor of Medicine at the Katholieke Universiteit Leuven, Belgium. She is Chair of Endocrinology at the University Hospital Gasthuisberg Leuven. Prof. Mathieu received her medical degree and PhD at the University of Leuven, where she subsequently completed training in internal medicine and endocrinology. Prof. Mathieu’s clinical areas of interest include organization of diabetes care. She is involved in several major clinical trials in type 1 and type 2 diabetes. Her basic research focuses on the prevention of type 1 diabetes, effects of vitamin D on the immune system and diabetes, and function of the insulin-producing beta cell.
Prof. Mathieu has authored or co-authored more than 330 peer-reviewed publications in international journals. She is a past associate editor and advisory board member of Diabetologia. In 2013, Prof. Mathieu received the prestigious inbev-baillet latour health prize Prize for Clinical Research for her pioneering research on the pathogenesis of type 1 diabetes. She presently coordinates the INNODIA project on prevention and intervention in type 1 diabetes in Europe.
Professor Simon Heller, BA, MB, BChir, DM, FRCP
University of Sheffield
Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, Director of Research and Development and Honorary Consultant Physician at Sheffield Teaching Hospitals Trust, UK. He received his clinical training at Queen’s Medical Centre, Nottingham and his research training at the University of Nottingham and Washington University, St Louis, USA. From 2000-2005 he was the editor of Diabetic Medicine. He is currently a member of Diabetes UK Science and Research Advisory Group, UK NIHR Health Technology Assessment Panel, UK Juvenile Diabetes Research Foundation and UK Scientific Advisory Committee.
During the period of 2005 – 2014, he chaired the Clinical Studies Advisory Group of the UK Diabetes Research Network and is currently the National Speciality Lead in Diabetes to the NIHR Clinical Research Network. He is an NIHR Senior Investigator. His current research interests include the pathophysiological responses to hypoglycaemia and hypoglycaemia unawareness, the potential contribution and mechanisms of hypoglycaemia to cardiovascular mortality, the use of insulin analogues and other technologies to reduce hypoglycaemia.
He chaired the glucose control group of the ADVANCE trial and is a steering committee member of the EXAMINE trial. He also conducts research programs focusing on developing interventions (including the DAFNE program) to encourage more effective diabetes self-management. He has authored over 200 original research articles and reviews.
Professor Sean Dinneen, MD FRCPI FACP
National University of Ireland
Seán Dinneen graduated from the University College of Cork Medical School in Ireland. After a period of postgraduate training in Ireland, he travelled to the USA, where he completed training in Internal Medicine and Endocrinology at the Mayo Clinic in Rochester, Minnesota. He was awarded a Mayo Foundation Scholarship and completed Masters in Clinical Epidemiology at McMaster University, Ontario, Canada before returning to a staff position in the Mayo Clinic in the Division of Endocrinology with a joint appointment to the Division of Health Services Research.
In 2000, he was appointed as a Community Diabetologist in Addenbrooke’s Hospital, Cambridge, UK, obtaining one of the first such appointments in the NHS. He returned to Ireland in 2005 as a Senior Lecturer in Medicine at National University of Ireland Galway (NUI Galway) and a Consultant Endocrinologist (Galway University Hospitals). He was the Head of the School of Medicine in NUI Galway from 2013 to 2016. In 2016, he was appointed National Lead for the Diabetes Clinical Programme of the Irish Health Service and received a Professorship from NUI Galway. He contribute to the development of a School of Podiatry and a Clinical Research Facility to NUI Galway.
His professional interests include developing and evaluating programs on educating and self-management for diabetic patients, developing optimal models for community-based diabetes care and understanding the diabetic foot.
He served as the Director in the Specialist Registrar Training Programme for Endocrinology and Diabetes Mellitus, at the Royal College of Physicians of Ireland from 2009 to 2014. He sits on the Postgraduate Education Committee of EASD (European Association for the Study of Diabetes) and co-ordinates conduction of Extra-European courses.
Professor Ali Jawa, MD (USA), MPH (USA), FACE (USA), FRCP (Lon), MIVM (Europe)
President, Pakistan Endocrine Society
Professor Ali Jawa is the President of the Pakistan Endocrine Society. He is also the immediate past President of the Pakistan chapter of the American Association of Clinical Endocrinologists. He is a member of the American board of Internal Medicine (ABIM) and ABIM-Endocrinology and Diabetes .He is also a member of the American Board of Physician Nutrition Specialists
Dr. S. Abbas Raza
Dr. S. Abbas Raza is works as a consultant Diabetologist /Endocrinologist at Shaukat Khanum Cancer Hospital & Research Center and the National Hospital in Lahore, Pakistan. Dr. Raza graduated from Allama Iqbal Medical College, Lahore Pakistan. He had his initial Medical training at the Atlantic City Medical Center, New Jersey, USA. His fellowship training for Diabetes, Endocrinology and Metabolism was at University of Wisconsin, Madison, U.S.A. He is a member of the American Board of Internal Medicine and a member of the American Board of Diabetes, Endocrinology & Metabolism.
Dr. Raza has many articles published in peer reviewed journals to his credit. He has also authored several chapters in books and manuals. He is actively involved in producing guidelines and consensus statements for South East Asia region related to Diabetes and Endocrinology. Dr. Raza is also a Chief Investigator for several national and International clinical trials.
Dr. Abbas Raza has served as a member of Board of Directors of American Association of Clinical Endocrinologist (AACE) during 2003-2004. He was awarded the Fellowship of American College of Endocrinology (FACE) in 2008. Dr. Raza is an Executive Member and Past- President of the Pakistan Endocrine Society (PES). He also holds the office of President -Elect of the South Asian Federation of Endocrine Societies (SAFES). He was also the founder President of AACE Chapter of Pakistan.
Dr Sanjay Kalra
Dr Sanjay Kalra serves as an endocrinologist at Bharti Hospital, Karnal, India. He serves as an Executive Editor of the Journal of Social Health and Diabetes, and holds editorial posts of various national and international medical journals. He is the vice President of the South Asian Federation of Endocrine Societies. Dr Kalra is an international lecturer and an author of numerous peer-reviewed research papers. He was a Section Editor, for several Endocrinology related manuals in India.
Dr Sanjay Kalra is a recipient of several national and international clinical awards, including the Investigator of the Year in 2008, awarded from the Indian Society of Clinical Research. He also received the DAWN Award in 2009.
He has many publications in peer review journals.
Dr Sandy Gupta, MD FRCP
Barts Health NHS Trust
Dr Gupta has been a Consultant Cardiologist at Whipps Cross and St Bartholomew’s Hospitals since 1999. He completed his undergraduate medical degree at St George’s Hospital Medical School in 1988. His clinical training in Cardiology had been at St Bartholomew’s, King’s College and St. George’s Hospitals.
Dr Gupta has been involved in the research area of ‘inflammation and heart disease’ and was awarded a British Heart Foundation (BHF) research fellowship. He is also the author of several text books, numerous published papers, editorials and many book chapters. Dr Gupta has also delivered over 250 invited guest lectures in major scientific symposia in over 60 different countries worldwide.
Dr Gupta is also involved in several projects with the NHS London/Olympics 2012 Health Legacy. He has also given several voluntary and community talks on heart disease awareness.
He is a Member several comittes and networks in the UK and is the Chair and Trustee of Whipps Cross Medical Education and Research Trust.
Dr. Katrien Benhalima MD, PhD,
Department of Endocrinology,
University Hospital Gasthuisberg Leuven, Belgium
Dr. Katrien Benhalima followed her training in internal medicine and endocrinology at the University hospital of Leuven, Belgium. After her graduation in 2009, she performed epidemiological research on the characteristics of young adults with type 2 diabetes at the diabetes department of Prof. Melanie Davies and Prof Kamlesh Khunti, University Hospitals of Leicester, UK. She is now a staff-member at the department of Endocrinology at the University Hospital Gasthuisberg Leuven. Her clinical areas of interest include new technologies for type 1 diabetes, type 2 diabetes in young adults, gestational diabetes and pre-gestational diabetes & pregnancy.
Her research is focused on evaluation of different screening strategies for gestational diabetes, the risk for glucose intolerance postpartum after gestational diabetes, pregnancy outcomes in type 1 diabetes and complications in young adults with type 2 diabetes. She was co-author of the most recent Flemish guidelines on the treatment of type 2 diabetes for general physicians. She is a member of the steering committee appointed by the ‘European Board and College of Obstetrics & Gynaecology’ (EBCOG) to develop a consensus on screening for gestational diabetes in Europe and she is an associated member of the Diabetic Pregnancy Study Group (DPSG).
She was the principal investigator of a large multi-centric Belgian cohort study on screening for gestational diabetes. She recently obtained her PhD on ‘gestational diabetes: Towards a uniform screening strategy’. She was recently awarded the rising star researcher award of Primary Care Diabetes Europe. She has published about 40 articles in international peer reviewed journals.